These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 7884013)
41. Immunological Dysfunction in Tourette Syndrome and Related Disorders. Hsu CJ; Wong LC; Lee WT Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33467014 [TBL] [Abstract][Full Text] [Related]
44. Normal caudate nucleus in obsessive-compulsive disorder assessed by quantitative neuroimaging. Aylward EH; Harris GJ; Hoehn-Saric R; Barta PE; Machlin SR; Pearlson GD Arch Gen Psychiatry; 1996 Jul; 53(7):577-84. PubMed ID: 8660124 [TBL] [Abstract][Full Text] [Related]
45. Autoimmune mechanisms in movement disorders. Visvanathan K; Trifiletti RR; Altemus M; Zabriskie JB Semin Pediatr Neurol; 2000 Jun; 7(2):103-7. PubMed ID: 10914411 [TBL] [Abstract][Full Text] [Related]
46. Increased antistreptococcal antibody titers and anti-basal ganglia antibodies in patients with Tourette syndrome: controlled cross-sectional study. Rizzo R; Gulisano M; Pavone P; Fogliani F; Robertson MM J Child Neurol; 2006 Sep; 21(9):747-53. PubMed ID: 16970879 [TBL] [Abstract][Full Text] [Related]
47. Microglial Dysregulation in OCD, Tourette Syndrome, and PANDAS. Frick L; Pittenger C J Immunol Res; 2016; 2016():8606057. PubMed ID: 28053994 [TBL] [Abstract][Full Text] [Related]
48. Antibodies against a neuron-like (HTB-10 neuroblastoma) cell in children with Tourette syndrome. Singer HS; Giuliano JD; Hansen BH; Hallett JJ; Laurino JP; Benson M; Kiessling LS Biol Psychiatry; 1999 Sep; 46(6):775-80. PubMed ID: 10494445 [TBL] [Abstract][Full Text] [Related]
49. Anti-brain autoantibodies and altered excitatory neurotransmitters in obsessive-compulsive disorder. Bhattacharyya S; Khanna S; Chakrabarty K; Mahadevan A; Christopher R; Shankar SK Neuropsychopharmacology; 2009 Nov; 34(12):2489-96. PubMed ID: 19675532 [TBL] [Abstract][Full Text] [Related]
50. A preliminary study of the frequency of anti-basal ganglia antibodies and streptococcal infection in attention deficit/hyperactivity disorder. Sanchez-Carpintero R; Albesa SA; Crespo N; Villoslada P; Narbona J J Neurol; 2009 Jul; 256(7):1103-8. PubMed ID: 19288046 [TBL] [Abstract][Full Text] [Related]
51. Autoantibodies against neurofilaments in Creutzfeldt-Jakob disease: immunofluorescence in sections of human caudate nucleus. Mayer V; Rajcáni J; Mitrová E Acta Virol; 1981 Nov; 25(6):390-4. PubMed ID: 6120641 [TBL] [Abstract][Full Text] [Related]
52. [Immunologic changes associated with tics, compulsive-obsessive disorder, and PANDAS]. Morer A; Massana J Med Clin (Barc); 2000 May; 114(17):665-8. PubMed ID: 10900608 [No Abstract] [Full Text] [Related]
53. Associations between somatomotor-putamen resting state connectivity and obsessive-compulsive symptoms vary as a function of stress during early adolescence: Data from the ABCD study. Petrie DJ; Meeks KD; Fisher ZF; Geier CF Brain Res Bull; 2024 May; 210():110934. PubMed ID: 38508468 [TBL] [Abstract][Full Text] [Related]
55. Identification of pyruvate kinase as an antigen associated with Tourette syndrome. Kansy JW; Katsovich L; McIver KS; Pick J; Zabriskie JB; Lombroso PJ; Leckman JF; Bibb JA J Neuroimmunol; 2006 Dec; 181(1-2):165-76. PubMed ID: 17011640 [TBL] [Abstract][Full Text] [Related]
56. Antibodies against human putamen in adolescents with anorexia nervosa. Harel Z; Hallett J; Riggs S; Vaz R; Kiessling L Int J Eat Disord; 2001 May; 29(4):463-9. PubMed ID: 11285584 [TBL] [Abstract][Full Text] [Related]
57. Neuropsychiatric-developmental model for the expression of tics, pervasive developmental disorder, and schizophreniform symptomatology associated with PANDAS. Cavanna AE; Martino D; Orth M; Giovannoni G; Stern JS; Robertson MM; Critchley HD World J Biol Psychiatry; 2009; 10(4 Pt 3):1037-8. PubMed ID: 18609435 [No Abstract] [Full Text] [Related]
58. Prevalence of serum antibodies to caudate nucleus in autistic children. Singh VK; Rivas WH Neurosci Lett; 2004 Jan; 355(1-2):53-6. PubMed ID: 14729233 [TBL] [Abstract][Full Text] [Related]
59. [Neuroimmunological aspects of the pathogenesis of Tourette syndrome and use of immunoglobulins in the treatment of children]. Zykov VP; Shcherbina AIu; Novikova EB; Shvabrina TV Zh Nevrol Psikhiatr Im S S Korsakova; 2008; 108(8):10-3. PubMed ID: 18833101 [TBL] [Abstract][Full Text] [Related]
60. Antibodies to neuronal surface proteins in Tourette Syndrome: Lack of evidence in a European paediatric cohort. Baglioni V; Coutinho E; Menassa DA; Giannoccaro MP; Jacobson L; Buttiglione M; Petruzzelli O; Cardona F; Vincent A; Brain Behav Immun; 2019 Oct; 81():665-669. PubMed ID: 31425826 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]